# aMoon

aMoon is a Private Equity based in Raanana, Israel.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Raanana, Israel
- **Region:** Middle East
- **Address:** Ra'anana, Israel
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** www.amoon.fund
- **LinkedIn:** https://www.linkedin.com/company/amoon

## About

aMoon partners with exceptional scientists and entrepreneurs to build great companies and accelerate cure. Through aMoon Velocity and aMoon Growth, the firm invests in early and late-stage companies pursuing disruptive, cutting-edge solutions for high unmet medical needs. It builds bridges between portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality.

## Sectors

- Digital Health
- Healthcare Services

## People

- Yair Schindel — MD, MBA — Co-Founder & Managing Partner
- Tomer Berkovitz — PhD — Managing Partner
- Todd Sone — MBA — General Partner
- Moshic Mor — MBA — General Partner
- Yaron Daniely — PhD, MBA — General Partner & Head of aMoon Alpha
- Reut Shema — PhD — Partner
- Roy Wiesner — Adv., MPA — Partner
- Patrick Rivers — MBA — Portfolio Manager
- Tamir Maixner — MBA — Principal
- Adam Kotzen — Principal
- Hagai Marmor-Kollet — PhD — Associate
- Rey Mozer — MD, MBA — Associate
- Daniel Sass — MD, MBA — Associate
- David Esra — MD — Analyst
- Sharon Feldman — PhD — Analyst
- Shachar Elias — Intern
- Irena Katsman — CPA, MBA — Chief Financial Officer
- Noam Waldoks — JD — Chief Legal Officer
- Osnat Tirosh — Chief People Officer & Chief of Staff
- Noah Lasson — JD, MBA — Chief Compliance Officer & CISO
- Gaby Hirsch — VP Investor Relations
- Yodfat Melzer — CPA, MBA — VP Finance
- David Dubinsky — CPA — Controller
- Isaac Devash — Venture Partner
- Samuel Moed — Venture Partner

## Questions

### What investment stages does aMoon target?

aMoon operates across the full HealthTech lifecycle. The firm's venture strategy covers early-stage, seed, and startup investments, while its growth equity vehicles target expansion and late-stage companies. This structure is designed to provide continuity of capital from initial product development through commercial scaling.

### Is aMoon a generalist venture firm or sector-specific?

aMoon is a pure-play HealthTech investor. The firm does not diversify into enterprise software, fintech, consumer internet, or other technology verticals. Its entire mandate is concentrated within healthcare services, digital health, and life sciences ventures emerging primarily from Israel's innovation ecosystem.

### Does aMoon invest exclusively in Israel?

aMoon's headquarters are in Ra'anana, and the firm's core sourcing model is anchored in Israel's academic and medical research institutions. While the firm targets companies with global regulatory strategies and international commercial ambitions, detailed geographic allocation data is not disclosed.

### How is aMoon structured as an asset manager?

aMoon functions as a multi-fund private equity manager. It operates separate early-stage venture vehicles alongside dedicated growth equity funds. This dual-fund architecture distinguishes it from single-fund health VCs and from large generalist growth platforms that treat healthcare as one of many sectors.

### Does aMoon participate in fund commitments or only direct deals?

Available information describes aMoon as a direct investor in private companies across venture and growth stages. There is no public disclosure of a fund-of-funds program or limited partner commitments to external PE or VC managers.

### Does aMoon disclose its assets under management?

No. aMoon does not publish an AUM figure, and no specific number has appeared in regulatory filings or media reports accessible for this review. The firm's financial scale is not publicly verifiable.

## Related profiles

- [Amonis](https://altss.com/profile/amonis)
- [AmorChem](https://altss.com/profile/amorchem)

---

Updated: 2026-08-11T15:06:04.815Z

Canonical page: https://altss.com/profile/amoon

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology